Location: Los Angeles, CA
CIK: 0001389933 · Show all filings
Period: Q4 2014 (← Previous) (Next →)
Filing Date: Feb 17, 2015
Total Value: $126M (94.2% shares, 5.8% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | PHARMACYCLICS INC | 110,928 | $13.56M | 10.7% | $81.75 | — | COM | 716933106 |
| ATRC | ATRICURE INC | 661,331 | $13.2M | 10.4% | $11.85 | +44.8% | COM | 04963C209 |
| — | AUSPEX PHARMACEUTICALS INC | 135,885 | $7.131M | 5.6% | $25.67 | — | COM | 05211J102 |
| — | NXSTAGE MEDICAL INC | 384,154 | $6.888M | 5.4% | $12.81 | — | COM | 67072V103 |
| — | DISCOVERY LABORATORIES INC | 5,698,739 | $6.611M | 5.2% | $2.01 | — | COM NEW | 254668403 |
| PODD | INSULET CORP | 109,418 | $5.04M | 4.0% | $28.33 | +51.0% | COM | 45784P101 |
| — | NOVADAQ TECHNOLOGIES INC | 263,541 | $4.38M | 3.5% | $13.46 | — | COM | 66987G102 |
| — | OCERA THERAPEUTICS INC | 634,893 | $4.044M | 3.2% | $6.00 | — | COM | 67552A108 |
| — | AERIE PHARMACEUTICALS INC | 132,442 | $3.866M | 3.1% | $20.69 | — | COM | 00771V108 |
| — | DERMA SCIENCES INC | 384,794 | $3.582M | 2.8% | $12.78 | — | COM PAR $.01 | 249827502 |
| — | INTERCEPT PHARMACEUTICALS IN | 21,900 | $3.416M | 2.7% | $145.83 | — | COM | 45845P108 |
| — | CTI BIOPHARMA CORP | 1,425,000 | $3.363M | 2.7% | $2.36 | — | COM | 12648L106 |
| — | PROTALIX BIOTHERAPEUTICS INC | 4,000,000 | $3.2M | 2.5% | $0.80 | — | NOTE 4.500% 9/1 | 74365AAB7 |
| — | INSULET CORP | 2,407,000 | $2.861M | 2.3% | $1.11 | — | NOTE 2.000% 6/1 | 45784PAD3 |
| — | PROTALIX BIOTHERAPEUTICS INC | 1,383,889 | $2.546M | 2.0% | $4.41 | — | COM | 74365A101 |
| — | ACHILLION PHARMACEUTICALS | 197,500 | $2.419M | 1.9% | $11.95 | — | COM | 00448Q201 |
| — | BIOTELEMETRY INC | 235,645 | $2.364M | 1.9% | $9.68 | — | COM | 090672106 |
| STXS | STEREOTAXIS INC | 1,374,975 | $2.035M | 1.6% | $2.92 | -40.2% | COM NEW | 85916J409 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 166,656 | $2.027M | 1.6% | $11.60 | -4.8% | COM | 09058V103 |
| MASI | MASIMO CORPORATION | 67,500 | $1.778M | 1.4% | $23.74 | +4.0% | COM | 574795100 |
| — | RIGEL PHARMACEUTICALS INC | 749,066 | $1.7M | 1.3% | $2.27 | — | COM NEW | 766559603 |
| — | THRESHOLD PHARMACEUTICALS | 530,965 | $1.688M | 1.3% | $4.20 | — | COM NEW | 885807206 |
| — | TREVENA INC | 280,000 | $1.674M | 1.3% | $5.98 | — | COM | 89532E109 |
| — | SPECTRANETICS CORP | 42,162 | $1.458M | 1.2% | $18.68 | — | COM | 84760C107 |
| — | NEOTHETICS INC | 186,495 | $1.395M | 1.1% | $7.48 | — | COM | 64066G101 |
| — | CLOVIS ONCOLOGY INC | 23,900 | $1.338M | 1.1% | $45.37 | — | COM | 189464100 |
| — | BIOSPECIFICS TECHNOLOGIES | 33,466 | $1.292M | 1.0% | $18.30 | — | COM | 090931106 |
| — | NUVASIVE INC | 1,000,000 | $1.289M | 1.0% | $0.99 | — | NOTE 2.750% 7/0 | 670704AC9 |
| — | TARGACEPT INC | 465,293 | $1.224M | 1.0% | $2.60 | — | COM | 87611R306 |
| — | VENAXIS INC | 658,000 | $1.165M | 0.9% | $2.12 | — | COM | 92262A107 |
| — | BLUEBIRD BIO INC | 12,500 | $1.147M | 0.9% | $35.88 | — | COM | 09609G100 |
| — | CYNAPSUS THERAPEUTICS INC | 949,000 | $1.044M | 0.8% | $1.10 | — | COM | 23257Y701 |
| — | CARDICA INC | 1,486,004 | $1.04M | 0.8% | $1.12 | — | COM | 14141R101 |
| — | UROPLASTY INC | 486,062 | $1.001M | 0.8% | $2.30 | — | COM NEW | 917277204 |
| JNJ | JOHNSON AND JOHNSON | 9,400 | $983K | 0.8% | $59.66 | +29.6% | COM | 478160104 |
| — | CYTRX CORP | 346,400 | $949K | 0.8% | $3.23 | — | COM PAR $.001 | 232828509 |
| — | CUTERA INC | 88,694 | $947K | 0.7% | $8.81 | — | COM | 232109108 |
| — | GALMED PHARMACEUTICALS LTD | 158,121 | $917K | 0.7% | $9.97 | — | SHS | M47238106 |
| ECIA | ENCISION INC | 1,062,500 | $882K | 0.7% | $0.98 | -15.4% | COM | 29254Q104 |
| — | XENOPORT INC | 98,190 | $861K | 0.7% | $4.98 | — | COM | 98411C100 |
| — | SYNERON MEDICAL LTD | 90,947 | $849K | 0.7% | $8.70 | — | ORD SHS | M87245102 |
| — | EXACTECH INC | 31,636 | $746K | 0.6% | $19.74 | — | COM | 30064E109 |
| — | AFFIMED THERAPEUTICS BV | 120,000 | $744K | 0.6% | $6.30 | — | COM ADDED | N01045108 |
| CDNA | CAREDX INC | 87,300 | $633K | 0.5% | $9.21 | -27.2% | COM ADDED | 14167L103 |
| — | INTELLIPHARMACEUTICS INTERNA | 279,260 | $631K | 0.5% | $2.45 | — | COM | 458173101 |
| QURE | UNIQURE B.V. | 39,656 | $587K | 0.5% | $11.22 | +9.1% | NV SHS | N90064101 |
| — | RTI SURGICAL INC | 85,918 | $447K | 0.4% | $3.76 | — | COM | 74975N105 |
| — | GENVEC INC | 200,000 | $416K | 0.3% | $2.37 | — | COM NEW | 37246C307 |
| — | SECOND SIGHT MED PRODS INC | 39,800 | $408K | 0.3% | $10.25 | — | COM | 81362J100 |
| — | LPATH INC | 121,884 | $344K | 0.3% | $4.45 | — | COM NEW | 548910306 |
| FATE | FATE THERAPEUTICS INC | 59,110 | $297K | 0.2% | $7.04 | -37.3% | COM | 31189P102 |
| — | LUMENIS LTD | 31,072 | $290K | 0.2% | $9.19 | — | SHS CL B | M6778Q121 |
| — | PROBIODRUG AG | 10,500 | $244K | 0.2% | $23.24 | — | COM | BRK8XK3 |
| — | CYNAPSUS THERAPEUTICS INC | 280,769 | $240K | 0.2% | $0.53 | — | COM | 23257Y156 |
| — | NANOSPHERE INC | 600,000 | $235K | 0.2% | $0.39 | — | COM | 63009F105 |
| — | ESSA PHARMA INC | 250,000 | $222K | 0.2% | $0.89 | — | PFD | 296991474 |
| — | CELSUS THERAPEUTICS PLC | 43,900 | $211K | 0.2% | $6.49 | — | SPONSORED ADR NE | 15119A202 |
| BLFS | BIOLIFE SOLUTIONS INC | 116,279 | $191K | 0.2% | $2.70 | -23.8% | COM NEW | 09062W204 |
| — | PROTEON THERAPEUTICS INC | 12,700 | $132K | 0.1% | $10.39 | — | COM | 74371L109 |
| — | CHEMBIO DIAGNOSTICS INC | 26,287 | $103K | 0.1% | $3.37 | — | COM NEW | 163572209 |
| GBIM | GLOBEIMMUNE INC | 10,945 | $83,000 | 0.1% | $10.17 | -31.4% | COM ADDED | 37957B100 |
| — | INSPIREMD INC | 63,700 | $50,000 | 0.0% | $2.21 | — | COM NEW | 45779A309 |